A detailed history of Swedbank Ab transactions in Exact Sciences Corp stock. As of the latest transaction made, Swedbank Ab holds 30,848 shares of EXAS stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,848
Holding current value
$1.73 Million
% of portfolio
0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$49.33 - $71.97 $1.52 Million - $2.22 Million
30,848 New
30,848 $1.73 Million
Q2 2024

Jul 18, 2024

SELL
$41.33 - $74.26 $903,060 - $1.62 Million
-21,850 Reduced 55.51%
17,515 $740,000
Q1 2024

May 21, 2024

BUY
$56.27 - $73.77 $2.22 Million - $2.9 Million
39,365 New
39,365 $2.72 Billion
Q4 2023

Dec 09, 2024

BUY
$59.06 - $75.72 $1.22 Million - $1.57 Million
20,700 Added 103.16%
40,765 $3.02 Million
Q3 2023

Dec 09, 2024

BUY
$65.94 - $99.04 $178,038 - $267,408
2,700 Added 15.55%
20,065 $1.37 Million
Q2 2022

Dec 09, 2024

SELL
$35.61 - $76.23 $29.2 Million - $62.6 Million
-820,583 Reduced 97.93%
17,365 $684,000
Q1 2022

Dec 09, 2024

BUY
$57.56 - $82.54 $2.23 Million - $3.19 Million
38,700 Added 4.84%
837,948 $58.6 Million
Q4 2021

Dec 09, 2024

SELL
$72.5 - $100.68 $3,117 - $4,329
-43 Reduced 0.01%
799,248 $62.2 Million
Q3 2021

Dec 09, 2024

SELL
$90.24 - $124.05 $8.82 Million - $12.1 Million
-97,777 Reduced 10.9%
799,291 $76.3 Million
Q2 2021

Dec 09, 2024

BUY
$93.66 - $139.27 $7.34 Million - $10.9 Million
78,337 Added 9.57%
897,068 $112 Million
Q1 2021

Dec 09, 2024

BUY
$116.57 - $155.01 $95.4 Million - $127 Million
818,731 New
818,731 $108 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.91B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.